High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients

BACKGROUND & AIMS: Adjuvant cytokine‐induced killer (CIK) cells treatment has shown potential in reducing the recurrence rate and prolonging the survival of patients with hepatocellular carcinoma (HCC). We aimed to identify the best predictive biomarker for adjuvant CIK cells treatment in patien...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Liver Int
Auteurs principaux: Chang, Boyang, Shen, Lujun, Wang, Kefeng, Jin, Jietian, Huang, Tao, Chen, Qifeng, Li, Wang, Wu, Peihong
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099434/
https://ncbi.nlm.nih.gov/pubmed/29356308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13697
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires